GoHealth, Inc.

NASDAQ:GOCO

12.4 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q22019 Q1
Revenue 118.292105.87185.6276.697132.037142.779183.15869.376133.052158.654270.593449.6211.734196.902204.179445.923163.36127.057141.01308.49174.51169.089
Cost of Revenue 23.51446.97864.25967.93335.99236.42245.46220.62948.04451.07467.92399.88653.63237.44248.37594.68225.82736.55942.13490.38426.56127.552
Gross Profit 94.77858.892121.341208.76496.045106.357137.69648.74785.008107.58202.67349.714158.102159.46155.804351.241137.53390.49898.876218.10747.9541.537
Gross Profit Ratio 0.8010.5560.6540.7540.7270.7450.7520.7030.6390.6780.7490.7780.7470.810.7630.7880.8420.7120.7010.7070.6440.601
Reseach & Development Expenses 000000000000000-4.593004.5936.00604.155
General & Administrative Expenses 17.1416.39816.91919.62912.96737.85522.61825.67125.61138.10629.21729.00724.23225.25119.69319.828156.55110.35910.49113.6747.1066.99
Selling & Marketing Expenses 45.2738.00452.77580.61439.41639.26945.74356.15122.66144.71484.033195.41159.51155.73554.48496.30962.84821.63426.07324.8115.02611.411
SG&A 62.4154.40269.694100.24352.38377.12468.36181.82248.27282.82113.25224.41883.74380.98674.177116.137219.39931.99336.56438.48512.13218.401
Other Expenses 75.04-0.648-125.373-183.704-0.771-0.02175.08499.79185.728100.806114.7280.6960.03-0.044-0.013-0.135-0.0020.505-0.010.017-0.038-0.01
Operating Expenses 137.45125.8125.373183.704134.021156.686143.445181.613134183.626227.978386.44206.721178.411154.402209.41335.32989.60688.649117.06432.24736.495
Operating Income -42.672-40.61-4.03225.06-37.976-53.016-5.696-132.866-48.992-76.046-25.371-423.279-48.619-18.9511.402141.831-197.796-14.4085.82724.09815.4045.042
Operating Income Ratio -0.361-0.384-0.0220.091-0.288-0.371-0.031-1.915-0.368-0.479-0.094-0.941-0.23-0.0960.0070.318-1.211-0.1130.0410.0780.2070.073
Total Other Income Expenses Net 58.027-18.744-17.385-26.975-18.336-17.286-16.838-17.267-15.515-12.711-11.461-8.923-6.891-20.256-8.701-8.727-8.638-8.481-11.166-89.223-0.119-0.038
Income Before Tax 15.355-59.354-21.417-1.915-56.312-70.302-22.587-150.445-74.654-113.752-36.769-432.202-55.51-39.207-7.299133.105-206.434-22.889-0.93916.03915.2855.004
Income Before Tax Ratio 0.13-0.561-0.115-0.007-0.426-0.492-0.123-2.169-0.561-0.717-0.136-0.961-0.262-0.199-0.0360.298-1.264-0.18-0.0070.0520.2050.072
Income Tax Expense -0.011-0.04-0.0710.379-0.108-0.073-0.0440.292-34.502-69.9330.4720.118-0.079-0.032-0.0310.0050.062-0.022-0.0020.0440.0090.002
Net Income 15.366-25.996-9.216-1.226-23.91-28.942-22.543-150.737-40.152-43.819-37.241-155.095-20.183-11.989-2.0935.957-56.42-22.867-0.93715.99515.2765.002
Net Income Ratio 0.13-0.246-0.05-0.004-0.181-0.203-0.123-2.173-0.302-0.276-0.138-0.345-0.095-0.061-0.010.081-0.345-0.18-0.0070.0520.2050.072
EPS 1.52-2.61-0.95-0.13-2.52-3.17-2.51-16.95-4.55-5.28-4.81-20.22-2.66-1.76-0.346.45-10.05-4.24-0.170.770.730.24
EPS Diluted 1.05-2.61-0.95-0.13-2.52-3.17-2.51-16.95-4.55-5.28-4.81-20.22-2.66-1.76-0.346.15-10.05-4.24-0.170.770.730.24
EBITDA -42.672-14.31222.7851.908-11.711-23.96120.518-106.288-20.927-74.6170.64-392.251-22.549-5.23826.769166.941-173.01910.61534.37452.85317.2086.58
EBITDA Ratio -0.361-0.1350.120.188-0.095-0.1680.097-1.576-0.156-0.3130.002-0.028-0.1060.0340.1310.374-1.0670.2040.2440.4210.230.095